Search company, investor...

Predict your next investment

Academic/University
tu-braunschweig.de

Portfolio Exits

1

About Technische Universität Braunschweig

Technische Universität Braunschweig is a Technische Universität in Germany. It was founded in 1745.

Headquarters Location

Universitätsplatz 2

Braunschweig, 38106,

Germany

+49 (0) 531 391-0

Want to inform investors similar to Technische Universität Braunschweig about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Technische Universität Braunschweig News

University adopts INTEGRA pipettes for prestigious international competition

Jan 12, 2023

Students of Technische Universität Braunschweig, Germany, used INTEGRA Biosciences’ VIAFLO electronic pipettes and EVOLVE manual pipettes to perform sample transfers and dilutions as part of their project for the 2022 iGEM competition. The pipettes helped the team to speed up liquid handling and increase pipetting accuracy, giving the students a competitive edge over their peers. The iGEM Foundation is an independent, non-profit organization dedicated to the advancement of all areas of synthetic biology. It runs an annual international competition where multidisciplinary teams of university students design, build and test their own unique research projects from start to finish. The group at Technische Universität Braunschweig (TU_BS) developed a self-amplifying detection system for the competition, which can be used to identify small amounts of tumor marker antigens in blood samples. This novel tool has the potential to contribute to the early diagnosis and treatment of many cancers, improving patient outcomes and survival rates in the long term. Related Stories Benjamin Harder, a student at TU_BS, explained: “We were the first iGEM team at our university for some time so, until recently, we had only a few outdated pipettes available to us. We therefore decided to upgrade to INTEGRA’s VIAFLO electronic pipettes and EVOLVE manual pipettes. They are well suited to our applications, as they allow us to rapidly adjust the dispensing volume on the fly, making our liquid handling steps faster and more efficient than before, while simultaneously minimizing manual errors and reagent wastage. This noticeably improved the accuracy and reproducibility of our results, giving us greater confidence in our findings.” “Every day working on our project in the lab was different and unpredictable, but INTEGRA’s products greatly helped us to deal with some of the surprises and challenges we came across as we got closer to the final of the exciting competition,” Benjamin concluded. All teams presented their cutting-edge projects during the iGEM Grand Jamboree in Paris, France, from the 26th to the 28th of October 2022, with prize winners being announced on the final day. TU_BS was awarded a silver medal for their innovative project, a much-deserved reward for the group’s months of hard work. Visit the INTEGRA Biosciences website to learn more.

Technische Universität Braunschweig Portfolio Exits

1 Portfolio Exit

Technische Universität Braunschweig has 1 portfolio exit. Their latest portfolio exit was OKAPI:Orbits on January 01, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/1/2018

Spinoff / Spinout

OKAPI:Orbits

$99M

1

Date

1/1/2018

Exit

Spinoff / Spinout

Companies

OKAPI:Orbits

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.